{"nctId":"NCT00693420","briefTitle":"Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence","startDateStruct":{"date":"2007-04"},"conditions":["Eyelashes"],"count":278,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost 0.03% sterile solution"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: vehicle sterile solution"]}],"interventions":[{"name":"Bimatoprost 0.03% sterile solution","otherNames":["LUMIGANÂ®"]},{"name":"vehicle sterile solution","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Dissatisfaction with eyelash prominence,\n* Eyelash prominence assessment of minimal or moderate,\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Subjects without visible lashes,\n* Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,\n* Any eye disease or abnormality,\n* Eye surgery,\n* Permanent eyeliner,\n* Eyelash implants,\n* Eyelash extension application,\n* Any use of eyelash growth products within 6 months of study entry,\n* Treatments that may effect hair growth,\n* Subjects requiring eye drop medications for glaucoma,\n* Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 16","description":"The GEA scale is an investigator-graded 4-point ordinal scale of overall eyelash prominence (1 \\[minimal\\], 2 \\[moderate\\], 3 \\[marked\\], 4 \\[very marked\\])","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.1","spread":null},{"groupId":"OG001","value":"2.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.6","spread":null},{"groupId":"OG001","value":"7.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.4","spread":null},{"groupId":"OG001","value":"14.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.3","spread":null},{"groupId":"OG001","value":"19.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78.1","spread":null},{"groupId":"OG001","value":"18.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16","description":"Upper eyelash length technologically measured in millimeters","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.79","spread":"0.815"},{"groupId":"OG001","value":"5.71","spread":"0.814"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.327"},{"groupId":"OG001","value":"0.00","spread":"0.327"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.22","spread":"0.371"},{"groupId":"OG001","value":"0.06","spread":"0.382"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"0.559"},{"groupId":"OG001","value":"0.07","spread":"0.396"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.16","spread":"0.722"},{"groupId":"OG001","value":"0.05","spread":"0.425"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.39","spread":"0.908"},{"groupId":"OG001","value":"0.11","spread":"0.425"}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)","description":"Upper eyelash length technologically measured in millimeters","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.47","spread":"0.831"},{"groupId":"OG001","value":"0.06","spread":"0.431"}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16","description":"Progressive thickness technologically measured within preset areas of lashes, expressed in pixels as percentage of the area of interest (AOI). 1 pixel is approximately equal to 0.0273 to 0.0274 mm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.16","spread":"8.089"},{"groupId":"OG001","value":"16.66","spread":"7.787"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.94","spread":"3.651"},{"groupId":"OG001","value":"0.24","spread":"3.161"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.62","spread":"4.031"},{"groupId":"OG001","value":"0.81","spread":"3.639"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.48","spread":"5.148"},{"groupId":"OG001","value":"0.75","spread":"4.189"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.30","spread":"7.328"},{"groupId":"OG001","value":"0.95","spread":"4.398"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.21","spread":"8.381"},{"groupId":"OG001","value":"1.10","spread":"3.984"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Patient Reported Outcome: Overall Satisfaction With Eyelashes (Single Item) in Terms of Change From Baseline to Week 16","description":"\"Overall, how satisfied are you with your eyelashes?\"\n\nPossible Answers on a 5 point scale as follows:\n\n1. \\- Very Satisfied\n2. \\- Satisfied\n3. \\- Neutral\n4. \\- Unsatisfied\n5. \\- Very Unsatisfied","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.18","spread":"0.788"},{"groupId":"OG001","value":"4.16","spread":"0.789"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"0.466"},{"groupId":"OG001","value":"-0.06","spread":"0.550"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.25","spread":"0.829"},{"groupId":"OG001","value":"-0.35","spread":"0.728"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.90","spread":"1.107"},{"groupId":"OG001","value":"-0.57","spread":"0.943"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.48","spread":"1.207"},{"groupId":"OG001","value":"-0.67","spread":"0.939"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.89","spread":"1.253"},{"groupId":"OG001","value":"-0.70","spread":"1.074"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 20 (Post-treatment)","description":"The GEA scale is an investigator-graded 4-point ordinal scale of overall eyelash prominence (1 \\[minimal\\], 2 \\[moderate\\], 3 \\[marked\\], 4 \\[very marked\\])","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.6","spread":null},{"groupId":"OG001","value":"21.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)","description":"Progressive thickness technologically measured within preset areas of lashes, expressed in pixels as percentage of the area of interest (AOI). 1 pixel is approximately equal to 0.0273 to 0.0274 mm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.16","spread":"7.051"},{"groupId":"OG001","value":"1.88","spread":"4.470"}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16","description":"Darkness was technologically measured in intensity units ranging from 0 (black) - 255 (white)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"105.67","spread":"20.349"},{"groupId":"OG001","value":"102.82","spread":"18.161"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.97","spread":"8.102"},{"groupId":"OG001","value":"-1.25","spread":"8.233"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.10","spread":"10.327"},{"groupId":"OG001","value":"-2.91","spread":"9.363"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.11","spread":"11.824"},{"groupId":"OG001","value":"-2.46","spread":"11.249"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.68","spread":"13.585"},{"groupId":"OG001","value":"-4.22","spread":"11.073"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.15","spread":"16.051"},{"groupId":"OG001","value":"-3.57","spread":"10.491"}]}]}]},{"type":"SECONDARY","title":"Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)","description":"Darkness was technologically measured in intensity units ranging from 0 (black) - 255 (white)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.12","spread":"14.943"},{"groupId":"OG001","value":"-5.51","spread":"10.789"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Patient Reported Outcome: Overall Satisfaction With Eyelashes (Single Item) in Terms of Change From Baseline to Week 20 (Post-treatment)","description":"\"Overall, how satisfied are you with your eyelashes?\" Possible Answers on a 5 point scale as follows: (1 - Very Satisfied; 2 - Satisfied; 3 - Neutral; 4 - Unsatisfied; 5 - Very Unsatisfied)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.06","spread":"1.345"},{"groupId":"OG001","value":"-0.61","spread":"1.128"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Upper respiratory tract infection","Eye pruritus","Pinguecula","Conjunctival hyperaemia","Eye Irritation"]}}}